| Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation G Solinas, G Germano, A Mantovani, P Allavena Journal of leukocyte biology 86 (5), 1065-1073, 2009 | 1817 | 2009 |
| Role of macrophage targeting in the antitumor activity of trabectedin G Germano, R Frapolli, C Belgiovine, A Anselmo, S Pesce, M Liguori, ... Cancer cell 23 (2), 249-262, 2013 | 938 | 2013 |
| Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth G Germano, S Lamba, G Rospo, L Barault, A Magrì, F Maione, M Russo, ... Nature 552 (7683), 116-120, 2017 | 612 | 2017 |
| Cytokines as a key component of cancer-related inflammation G Germano, P Allavena, A Mantovani Cytokine 43 (3), 374-379, 2008 | 411 | 2008 |
| SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo S Mainardi, A Mulero-Sánchez, A Prahallad, G Germano, A Bosma, ... Nature medicine 24 (7), 961-967, 2018 | 322 | 2018 |
| Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells G Germano, R Frapolli, M Simone, M Tavecchio, E Erba, S Pesce, ... Cancer research 70 (6), 2235-2244, 2010 | 305 | 2010 |
| Chemokines in cancer related inflammation P Allavena, G Germano, F Marchesi, A Mantovani Experimental cell research 317 (5), 664-673, 2011 | 300 | 2011 |
| Cancer‐promoting tumor‐associated macrophages: New vistas and open questions A Mantovani, G Germano, F Marchesi, M Locatelli, SK Biswas European journal of immunology 41 (9), 2522-2525, 2011 | 249 | 2011 |
| Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer BO Van Emburgh, S Arena, G Siravegna, L Lazzari, G Crisafulli, G Corti, ... Nature communications 7 (1), 13665, 2016 | 212 | 2016 |
| High-dose vitamin C enhances cancer immunotherapy A Magrì, G Germano, A Lorenzato, S Lamba, R Chilà, M Montone, ... Science translational medicine 12 (532), eaay8707, 2020 | 211 | 2020 |
| PTPN11 is a central node in intrinsic and acquired resistance to targeted cancer drugs A Prahallad, GJJE Heynen, G Germano, SM Willems, B Evers, ... Cell reports 12 (12), 1978-1985, 2015 | 193 | 2015 |
| The clinical impact of the genomic landscape of mismatch repair–deficient cancers G Germano, N Amirouchene-Angelozzi, G Rospo, A Bardelli Cancer discovery 8 (12), 1518-1528, 2018 | 109 | 2018 |
| Tumor-associated macrophages as incessant builders and destroyers of the cancer stroma M Liguori, G Solinas, G Germano, A Mantovani, P Allavena Cancers 3 (4), 3740-3761, 2011 | 102 | 2011 |
| RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas E Fagiani, G Giardina, L Luzi, M Cesaroni, M Quarto, M Capra, ... Cancer research 67 (7), 3064-3073, 2007 | 88 | 2007 |
| Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients G Crisafulli, A Sartore-Bianchi, L Lazzari, F Pietrantonio, A Amatu, ... Cancer Discovery 12 (7), 1656-1675, 2022 | 70 | 2022 |
| Trabectedin: A drug from the sea that strikes tumor-associated macrophages P Allavena, G Germano, C Belgiovine, M D’Incalci, A Mantovani Oncoimmunology 2 (6), e24614, 2013 | 69 | 2013 |
| Evolving neoantigen profiles in colorectal cancers with DNA repair defects G Rospo, A Lorenzato, N Amirouchene-Angelozzi, A Magrì, C Cancelliere, ... Genome medicine 11, 1-22, 2019 | 58 | 2019 |
| CD4 T cell–dependent rejection of beta-2 microglobulin null mismatch repair–deficient tumors G Germano, S Lu, G Rospo, S Lamba, B Rousseau, S Fanelli, D Stenech, ... Cancer discovery 11 (7), 1844-1859, 2021 | 57 | 2021 |
| Mechanisms of immune escape and resistance to checkpoint inhibitor therapies in mismatch repair deficient metastatic colorectal cancers V Amodio, G Mauri, NM Reilly, A Sartore-Bianchi, S Siena, A Bardelli, ... Cancers 13 (11), 2638, 2021 | 51 | 2021 |
| Parallel evaluation of circulating tumor DNA and circulating tumor cells in metastatic colorectal cancer G Germano, G Mauri, G Siravegna, C Dive, J Pierce, F Di Nicolantonio, ... Clinical Colorectal Cancer 17 (1), 80-83, 2018 | 46 | 2018 |
